Straight from the Desk
Syz the moment
Live feeds, charts, breaking stories, all day long.
- All
- equities
- United States
- Macroeconomics
- Food for Thoughts
- markets
- bitcoin
- Central banks
- geopolitics
- Fixed Income
- AI
- Asia
- gold
- europe
- Commodities
- investing
- Technology
- Crypto
- technical analysis
- nvidia
- china
- oil
- ETF
- earnings
- Forex
- energy
- banking
- magnificent-7
- Volatility
- Alternatives
- Real Estate
- apple
- emerging-markets
- Middle East
- switzerland
- tesla
- amazon
- United Kingdom
- microsoft
- assetmanagement
- ethereum
- russia
- meta
- Healthcare
- Industrial-production
- ESG
- Global Markets Outlook
- bankruptcy
- Turkey
- brics
- inflation
- Market Outlook
- performance
- africa
- LLM
- Global
- Market News
- Weekly Equities
SpaceX surged to $229.40 on Robinhood, pushing its market cap to over $3 trillion during overnight trading, surpassing both Amazon and Microsoft.
SpaceX is currently trading at $213.59 after hours, up +11% from its closing price. $SPCX is up +58.2% from its IPO price of $135. Source: Bull Theory
SOX is up roughly 18% since the June 9 low.
In just a few sessions, we have gone from the bottom of the range to the top, bouncing off the steep trend line despite briefly trading below the 21-day moving average. The moves have been absolutely brutal. For larger players, reshuffling big books in an environment like this is close to impossible. An 18% move in five sessions in the world's hottest theme is actually crazy when you stop and think about it. Chasing SOX after an 18% rally in five sessions feels a little late. Fading it feels dangerous. Source: TME
If you were looking for cross-assets correlation... Below chart is Hyperscalers vs token prices...
Source: Bloomberg, zerohedge
Cybersecurity stocks are up +29.5% YTD while software has barely broken even
Source: Hedgeye
Tough to be bearish when you see such a chart...
Of course, these are estimates and they need to be met. Source: 3fourteeenresearch
Investing with intelligence
Our latest research, commentary and market outlooks

